Glaukos Total Assets 2014-2024 | GKOS

Glaukos total assets from 2014 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Glaukos total assets for the quarter ending June 30, 2024 were $0.920B, a 3.87% decline year-over-year.
  • Glaukos total assets for 2023 were $0.94B, a 6.18% decline from 2022.
  • Glaukos total assets for 2022 were $1.002B, a 4.51% decline from 2021.
  • Glaukos total assets for 2021 were $1.05B, a 4.4% increase from 2020.
Glaukos Annual Total Assets
(Millions of US $)
2023 $940
2022 $1,002
2021 $1,050
2020 $1,006
2019 $818
2018 $207
2017 $166
2016 $134
2015 $117
2014 $26
2013 $31
Glaukos Quarterly Total Assets
(Millions of US $)
2024-06-30 $920
2024-03-31 $933
2023-12-31 $940
2023-09-30 $949
2023-06-30 $957
2023-03-31 $973
2022-12-31 $1,002
2022-09-30 $1,008
2022-06-30 $1,031
2022-03-31 $1,052
2021-12-31 $1,050
2021-09-30 $1,064
2021-06-30 $1,044
2021-03-31 $1,023
2020-12-31 $1,006
2020-09-30 $995
2020-06-30 $996
2020-03-31 $780
2019-12-31 $818
2019-09-30 $307
2019-06-30 $302
2019-03-31 $228
2018-12-31 $207
2018-09-30 $191
2018-06-30 $171
2018-03-31 $163
2017-12-31 $166
2017-09-30 $153
2017-06-30 $146
2017-03-31 $138
2016-12-31 $134
2016-09-30 $129
2016-06-30 $124
2016-03-31 $116
2015-12-31 $117
2015-09-30 $118
2015-06-30 $128
2015-03-31 $28
2014-12-31 $26
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.219B $0.315B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $212.467B 25.92
Intuitive Surgical (ISRG) United States $180.733B 94.49
Alcon (ALC) Switzerland $45.462B 32.00
Edwards Lifesciences (EW) United States $40.042B 24.90
IQVIA Holdings (IQV) United States $38.149B 21.02
IDEXX Laboratories (IDXX) United States $33.943B 39.97
DexCom (DXCM) United States $27.225B 41.00
Waters (WAT) United States $22.999B 34.01
STERIS (STE) Ireland $22.270B 25.99
SONOVA HOLDING (SONVY) Switzerland $21.961B 0.00
Hologic (HOLX) United States $19.446B 20.52
Fresenius Medical Care AG KGaA (FMS) Germany $11.766B 13.19
Sysmex ADR (SSMXY) Japan $11.599B 36.37
Globus Medical (GMED) United States $10.118B 28.30
Teleflex (TFX) United States $9.629B 15.36
Penumbra (PEN) United States $8.808B 86.28
Masimo (MASI) United States $7.841B 41.99
PROCEPT BioRobotics (PRCT) United States $5.065B 0.00
Integer Holdings (ITGR) United States $4.244B 24.06
Inari Medical (NARI) United States $2.865B 0.00
TransMedics (TMDX) United States $2.852B 90.39
Veracyte (VCYT) United States $2.687B 166.57
LivaNova (LIVN) United Kingdom $2.661B 15.36
Nihon Kohden (NHNKY) Japan $2.561B 15.94
Elekta AB (EKTAY) Sweden $2.323B 18.92
Tandem Diabetes Care (TNDM) United States $2.151B 0.00
RxSight (RXST) United States $1.896B 0.00
Integra LifeSciences Holdings (IART) United States $1.871B 9.73
Alphatec Holdings (ATEC) United States $1.185B 0.00
Artivion (AORT) United States $1.150B 105.61
OPKO Health (OPK) United States $1.032B 0.00
Pulse Biosciences (PLSE) United States $0.934B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.883B 15.01
OrthoPediatrics (KIDS) United States $0.696B 0.00
Pacific Biosciences Of California (PACB) United States $0.684B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.662B 0.00
Mesa Laboratories (MLAB) United States $0.641B 16.18
IRadimed (IRMD) United States $0.626B 33.81
AxoGen (AXGN) United States $0.622B 0.00
SiBone (SIBN) United States $0.568B 0.00
Paragon 28 (FNA) United States $0.506B 0.00
CVRx (CVRX) United States $0.365B 0.00
Tactile Systems Technology (TCMD) United States $0.359B 19.62
ClearPoint Neuro (CLPT) United States $0.352B 0.00
Treace Medical Concepts (TMCI) United States $0.338B 0.00
Delcath Systems (DCTH) United States $0.299B 0.00
AngioDynamics (ANGO) United States $0.274B 0.00
Sight Sciences (SGHT) United States $0.234B 0.00
Inogen (INGN) United States $0.214B 0.00
Semler Scientific (SMLR) United States $0.210B 14.62
Nevro (NVRO) United States $0.199B 0.00
NeuroPace (NPCE) United States $0.186B 0.00
Accuray (ARAY) United States $0.180B 0.00
Atossa Genetics (ATOS) United States $0.177B 0.00
Alpha Tau Medical (DRTS) Israel $0.156B 0.00
KORU Medical Systems (KRMD) United States $0.123B 0.00
Spectral Diagnostics (EDTXF) Canada $0.122B 0.00
908 Devices (MASS) United States $0.116B 0.00
Sensus Healthcare (SRTS) United States $0.104B 15.51
EDAP TMS S.A (EDAP) France $0.100B 0.00
WORK Medical Technology Group (WOK) China $0.086B 0.00
Monogram Orthopaedics (MGRM) United States $0.080B 0.00
Hyperfine (HYPR) United States $0.070B 0.00
LENSAR (LNSR) United States $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.068B 0.00
InspireMD (NSPR) Israel $0.062B 0.00
Lucid Diagnostics (LUCD) United States $0.051B 0.00
Vicarious Surgical (RBOT) United States $0.048B 0.00
Rapid Micro Biosystems (RPID) United States $0.046B 0.00
Envoy Medical (COCH) United States $0.046B 0.00
EnVVeno Medical (NVNO) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.044B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Neuronetics (STIM) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Precision Optics (POCI) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.025B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
NexGel (NXGL) United States $0.019B 0.00
Baird Medical Investment Holdings (BDMD) $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
T2 Biosystems (TTOO) United States $0.014B 0.00
Autonomix Medical (AMIX) United States $0.013B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Pixie Dust Technologies (PXDT) Japan $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Check-Cap (CHEK) Israel $0.007B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00